{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13"],"submitter":["Sun T"],"funding":["National Natural Science Foundation of China"],"pubmed_abstract":["The inflammasome has been linked to diverse inflammatory and metabolic diseases, and tight control of inflammasome activation is necessary to avoid excessive inflammation. Kynurenic acid (KA) is a tryptophan metabolite in the kynurenine pathway. However, the roles and mechanisms of the regulation of inflammasome activation by KA have not yet been fully elucidated. Here, we found that KA suppressed caspase-1 activation and IL-1β production in macrophages by specifically inhibiting canonical and noncanonical activation of the NLRP3 inflammasome. Mechanistically, KA reduced calcium mobilization through G-protein receptor 35 (GPR35), resulting in reduced mitochondrial damage and decreased mtROS production, thus blocking NLRP3 inflammasome assembly and activation. Importantly, KA prevented lipo"],"journal":["Frontiers in immunology"],"pagination":["1019365"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9606686"],"repository":["biostudies-literature"],"pubmed_title":["Kynurenic acid ameliorates NLRP3 inflammasome activation by blocking calcium mobilization <i>via</i> GPR35."],"pmcid":["PMC9606686"],"pubmed_authors":["Cheng C","Yin W","Kang G","Li J","He H","Sun T","Cong J","Wang X","Xie Q","Xie R","Zhao X"],"additional_accession":[]},"is_claimable":false,"name":"Kynurenic acid ameliorates NLRP3 inflammasome activation by blocking calcium mobilization <i>via</i> GPR35.","description":"The inflammasome has been linked to diverse inflammatory and metabolic diseases, and tight control of inflammasome activation is necessary to avoid excessive inflammation. Kynurenic acid (KA) is a tryptophan metabolite in the kynurenine pathway. However, the roles and mechanisms of the regulation of inflammasome activation by KA have not yet been fully elucidated. Here, we found that KA suppressed caspase-1 activation and IL-1β production in macrophages by specifically inhibiting canonical and noncanonical activation of the NLRP3 inflammasome. Mechanistically, KA reduced calcium mobilization through G-protein receptor 35 (GPR35), resulting in reduced mitochondrial damage and decreased mtROS production, thus blocking NLRP3 inflammasome assembly and activation. Importantly, KA prevented lipo","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2026-05-31T15:47:50.384Z","creation":"2025-04-04T12:45:12.684Z"},"accession":"S-EPMC9606686","cross_references":{"pubmed":["36311752"],"doi":["10.3389/fimmu.2022.1019365"]}}